Q: I hold Gardant in a riff. I am down 70% on the name. I am thinking of selling to look for better opportunities. Could I have your opinion please. Thank you.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: 1. has well ever been in a profit since inception if so what year and what was the EPS. that year. .2. what is the EPS projection for WELL for 2024 year . 3. what is the projection for EPS for 2025 year. 4. what is the share count for years ended 2022 and 2023. 5. have the insiders been buying more shares at depressed market prices or just exercising options at lower prices and selling.into the market thanks Richard
Q: Hi 5i Team,
May I please have your thoughts on UNH? Is it a hold, sell or buy? Would you also recommend an alternative to it.
Cheers,
Harry
May I please have your thoughts on UNH? Is it a hold, sell or buy? Would you also recommend an alternative to it.
Cheers,
Harry
Q: Good Morning
Your thoughts on WELL’s transaction with Healwell please.
Thank you
Your thoughts on WELL’s transaction with Healwell please.
Thank you
Q: Hi 5i
Hum down 15% today after earnings and a poor guidance.....also CVS down ...What is your opinion on HUM and what does the future look like for these companies....short term/long term.
Is this industry in trouble?
Where do you see things go from here and a what price does this company become attractive investment.
thx
Hum down 15% today after earnings and a poor guidance.....also CVS down ...What is your opinion on HUM and what does the future look like for these companies....short term/long term.
Is this industry in trouble?
Where do you see things go from here and a what price does this company become attractive investment.
thx
Q: Savaria having a great Week. Overall what do you see and what do you think about the upcoming Year on SIS. Thanks. Barry
Q: I expect many will ask but I'll join the crowd anyways- what do you folks think about the release today? They seem to be doing, "well." I thought the organic growth was a good sign...
Q: Has anything(s) notable changed on WELL since your last Aug 29 2022 report including metrics on this company?
Q: Thoughts on the quarter and would you be a buyer here? Interesting reaction to the earnings though- it was up in AH trading but is basically unchanged now. Is it too expensive?
Q: Down again on heavy volume. Do you have the means to see if these are borrowed shares for a short attack.
Thanks Steve
Thanks Steve
Q: BMY:
1 What is your current assessment of BMY?
2. Its share price has dropped in the last year. Does it have reasonable prospects to increase from here?
3. It has a somewhat attractive dividend, around 4.75%. Is that sustainable? Does it have any history of dividend increases?
4. Can you describe its pipeline potential?
Many thanks for your excellent service.
1 What is your current assessment of BMY?
2. Its share price has dropped in the last year. Does it have reasonable prospects to increase from here?
3. It has a somewhat attractive dividend, around 4.75%. Is that sustainable? Does it have any history of dividend increases?
4. Can you describe its pipeline potential?
Many thanks for your excellent service.
Q: Hello,
I am wondering about the merit of purchasing NBLY shares prior to the deal close in order to acquire the Contingent Value Rights (CVR). My thinking is that this would require a short term commitment of capital that could potentially yield a payout in 2026. How likely is it that the EBITDA Target of $128M will be met? If one were to proceed with this strategy when would the shares need to be purchased?
Thank-you
I am wondering about the merit of purchasing NBLY shares prior to the deal close in order to acquire the Contingent Value Rights (CVR). My thinking is that this would require a short term commitment of capital that could potentially yield a payout in 2026. How likely is it that the EBITDA Target of $128M will be met? If one were to proceed with this strategy when would the shares need to be purchased?
Thank-you
Q: GILD is down 10% after its phase 3 trial of Trodelvy in a lung cancer trial failed to meet its primary end-point. Is this just "noise" or a reason for a long-term shareholder to sell?
Q: Hi
With a 13% haircut today, and nothing has changed!! (just some dude's opinion, which are like belly buttons, everybody has one)
I bought more call me crazy but I think in the end it will work out give it another few years.
Is my thinking wrong??.
Take care folks
Mike
With a 13% haircut today, and nothing has changed!! (just some dude's opinion, which are like belly buttons, everybody has one)
I bought more call me crazy but I think in the end it will work out give it another few years.
Is my thinking wrong??.
Take care folks
Mike
Q: Hi,
Is this a good time to increase my position in WELL? Where do you see it in 5 years?
Thanks
Is this a good time to increase my position in WELL? Where do you see it in 5 years?
Thanks
Q: Any idea why CIBC lowered their rating to neutral with a target of $4.75?
Q: The news on well health has been good lately; how is it that analysts all of a sudden lower their ratings.. It makes me wonder if there is some manipulation going on unless they are seeing Well not as attractive all of a sudden. Your responses of late have been positive and i know opinions can differ. Can you shed some light please?
Q: Good Morning
Anything to explain the negative action on WELL this morning?
Anything to explain the negative action on WELL this morning?
Q: Hello Team,
For steady longterm growth, which would you choose and why from these two companies in the health care area.
Thanks,
Barry
For steady longterm growth, which would you choose and why from these two companies in the health care area.
Thanks,
Barry
Q: As a follow up to the health care question posted on Jan. 15, what are your thoughts on NVO? I think that is has a similar market cap as LLY.
Thanks
Joe
Thanks
Joe